Clinical Trials Sponsored by TrialX Inc

Total 38023 results

Neuroscience Trials Australia

Terminated

Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial (EXTEND-IA)

Ischemic Stroke

Australia, New Zealand
Cancer Trials Ireland

Completed

Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck Cancer

Head and Neck Cancer

Ireland
Cancer Trials Ireland

Completed

Sorafenib. ICORG 06-41, V4

Gastric Cancer | Esophageal Cancer

Ireland
Cancer Trials Ireland

Completed

Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

Ireland
Cancer Trials Ireland

Completed

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Malignant Mesothelioma

United Kingdom, Ireland, Belgium, Netherlands
Cancer Trials Ireland

Completed

A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer (ELECT)

Gastro Oesophageal Cancer

Ireland
Canadian Cancer Trials Group
Stand Up To Cancer; Senhwa Biosciences, Inc.

Completed

A Phase I Study of CX5461

Cancer

Canada
Prostate Cancer Clinical Trials Consortium
University of Chicago; Astellas Pharma Inc

Terminated

Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer (Doce/Enza)

Prostate Cancer

United States
University of California, San Diego
E Squared Trials and Registries, Inc.

Completed

U.S. CTEPH Registry

Pulmonary Hypertension | Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

United States
NJOY, Inc.
National Institute on Drug Abuse (NIDA); LA Clinical Trials

Completed

Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users

Cigarette Smoking

United States
R-Pharm International, LLC
Quintiles, Inc.; OCT Clinical Trials

Completed

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease (CREDO 2)

Rheumatoid Arthritis

United States, Germany, Korea, Republic of, Bulgaria, Poland, Taiwan, Mexico, Hungary, Czechia, United Kingdom, Lithuania, Argentina, Brazil, Colombia, Estonia, Latvia, Russian Federation, Romania
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Astellas Pharma Inc; OSI Pharmaceuticals

Completed

Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Pancreatic Cancer

United States, Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene Corporation

Active, not recruiting

Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma

Multiple Myeloma in Relapse

United States
Heinrich-Heine University, Duesseldorf
Abiomed Inc.; Profil Clinical Trials Coordination GmbH

Recruiting

Protect Kidney Trial

High-risk Percutaneous Coronary Intervention | Induced Acute Kidney Injury

Germany
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Canadian Cancer Trials Group

Active, not recruiting

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Lobular Breast Carcinoma | Ductal Breast Carcinoma | Tubular Breast Carcinoma | Medullary Breast Carcinoma

United States, Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Canadian Cancer Trials Group

Active, not recruiting

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

Stage II Breast Cancer | Stage IIIA Breast Cancer

United States, Canada, Puerto Rico
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Canadian Cancer Trials Group

Active, not recruiting

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Colorectal Cancer

United States, Canada, Israel, Switzerland
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer

Breast Cancer

United States, Canada, Peru
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)

Kidney Cancer

United States, Canada
Australasian Gastro-Intestinal Trials Group
Canadian Cancer Trials Group

Not yet recruiting

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (STOPNET)

Neuroendocrine Tumors

Australia
Canadian Cancer Trials Group
Canadian Cancer Clinical Trials Network

Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Endometrial Cancer

Canada, Australia, Netherlands
NCIC Clinical Trials Group
GlaxoSmithKline

Completed

MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy

Lung Cancer

Canada
NCIC Clinical Trials Group
ZymoGenetics

Completed

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Melanoma (Skin)

Canada
NCIC Clinical Trials Group
GlaxoSmithKline

Completed

A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer (IND197)

Recurrent Breast Cancer

Canada
NCIC Clinical Trials Group
Pfizer

Completed

PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

Lung Cancer

Taiwan, Canada, Australia, Italy, New Zealand, United States, Thailand, Korea, Republic of, Brazil, Argentina, Philippines, Peru
NCIC Clinical Trials Group
Pfizer

Completed

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Canada
NCIC Clinical Trials Group
GlaxoSmithKline

Completed

Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer

Breast Cancer

Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer

United States, Canada, South Africa, Puerto Rico
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

Breast Cancer

United States, Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer

Colorectal Cancer

United States, Canada, Puerto Rico
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite

Anorexia | Cachexia

Canada, United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Genetic Study in Patients With Stage II or Stage III Colon Cancer

Colorectal Cancer

Canada, United States
Listen Trial Group

Completed

LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts (LISTEN)

Hypercholesterolemia With Concomitant Type 2 Diabetes

Japan
Acrobat Trial Group

Unknown

ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) (ACROBAT)

Hypertension and Atrial Fibrillation

Japan
NCIC Clinical Trials Group
AstraZeneca

Completed

AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

Canada
NCIC Clinical Trials Group
Bayer

Completed

Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

Canada
NCIC Clinical Trials Group
AstraZeneca

Completed

AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pancreatic Cancer

Canada
Biomat USA, Inc.
Axio Research. LLC; Hammond Clinical Trial Consulting, LLC

Completed

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

Healthy

United States
Bexion Pharmaceuticals, Inc.
ICON plc; CTI Clinical Trial and Consulting Services

Recruiting

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma (ASIST)

Neuropathy | Metastatic Colorectal Carcinoma

United States
GlaxoSmithKline
Quintiles, Inc.; ERT: Clinical Trial Technology Solutions; Q2 Solutions; HemoCue

Completed

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)

Anaemia

United States
Embera NeuroTherapeutics, Inc.
Rose Research Center, LLC; Segal Trials; Foundation for a Smoke Free World INC

Terminated

Study of EMB-001 as a Potential Smoking Cessation Treatment

Tobacco Use Disorder

United States
Mast Therapeutics, Inc.
Worldwide Clinical Trials; Synteract, Inc.; Thywill Latam Solutions SRL; OCASA...

Completed

A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

Breast Cancer | Non-small Cell Lung Cancer | Non-Hodgkins Lymphoma

Argentina
MICE Trial Group

Unknown

Melatonin Use in the Intensive Care Elderly Population (MICE)

Delirium | Melatonin

United States
Positive Trial Group

Terminated

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments (POSITIVE)

Hypertension | Type 2 Diabetes | Hypercholesterolemia

Japan
Canadian Cancer Trials Group
Roche Pharma AG; Janssen, LP; Karyopharm Therapeutics Inc

Recruiting

Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma

Lymphoma

Canada
Turkish Stroke Research and Clinical Trials Network
ElectroCore INC; Turkish Neurological Society

Completed

Non-invasive TRanscutaneous Cervical Vagus Nerve Stimulation as a Treatment for Acute Stroke; Safety and Feasibility Study (TR-VENUS)

Stroke | Stroke, Ischemic | Stroke, Acute | Stroke, Hemorrhagic

Turkey
Akorn, Inc.
South Florida Family Health and Research Centers; Axis Clinical Trials

Completed

Bioequivalence Study for Benzyl Alcohol Lotion 5%.

Head Lice

United States
Matinas BioPharma Nanotechnologies, Inc.
University of Cologne; The Clinical Trials Centre Cologne

Withdrawn

Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...

Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma | Recurrent Meningioma | NF2 Gene Mutation

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Gilead Sciences; Celgene Corporation; Biologics...

Completed

Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Relapsed/Refractory Mantle Cell Lymphoma

United States

Clinical Trials Sponsored by TrialX Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations